Indivior | Kostnadene For Salg



Cost Of Sales Endring Dato
AstraZeneca USD 2.24B 484M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
Indivior 44M 21M 2025-03
J&J USD 7.3B 189M 2025-03
Kyowa Hakko Kirin JPY 24.59B 9.95B 2025-03
Merck USD 2.76B 944M 2025-03
Novartis USD 3.31B 73M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12



Indivior Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.